Coverage
-
November 07, 2016
An alleged pay-for-delay scheme in which Teva Pharmaceuticals Industries Ltd. and others kept a generic version of the sleep disorder drug Provigil off the market belongs in Minnesota because the drugmaker knew it would be ripping off customers in the state, United Healthcare Services Inc. said Friday.
2 other articles on this case.
View all »